Research Journal of Pharmacy and Technology

SCOPUS
  • Year: 2019
  • Volume: 12
  • Issue: 11

Anti-Inflammatory, Antiviral Veterinary Medicine with Immuno-Modulating Activity

  • Author:
  • Nataliya N Borisenko1, Inna V Bushueva2,, Volodymyr V Parchenko3, Inna Ya Gubenko1, Yevhenii O Mykhailiuk2, Olha I Riznyk4, Oleksandr G Aleksieiev5, Bohdan V Gutyj6, Hanna P Lysianska7, Anton V Kurinnyi7
  • Total Page Count: 5
  • Page Number: 5255 to 5259

1Cherkasy Medical Academy, Cherkasy, Ukraine

2Department of the Clinical Pharmacy, Pharmacotherapy and MFE, Zaporizhzhia State Medical University, Zaporizhzhia, Ukraine

3Department of Natural Sciences for Foreign Students and Toxicological Chemistry, Zaporizhzhia State Medical University, Zaporizhzhia, Ukraine

4Department of the Health Care, Social Medicine and Medical Labor Examination, Zaporizhzhia State Medical University, Zaporizhzhia, Ukraine

5Department of Management and Economics of Pharmacy, Medical and Pharmaceutical Law, Zaporizhzhia State Medical University, Zaporizhzhia, Ukraine

6Department of Pharmacology and Toxicology, Stepan Gzhytskyi National University of Veterinary Medicine and Biotechnologies Lviv, Lviv, Ukraine

7Department of Drug Technology, Zaporizhzhia State Medical University, Zaporizhzhia, Ukraine

*Corresponding Author E-mail: valery999@ukr.net

Online published on 9 April, 2020.

Abstract

The aim of this development is an estimation of the efficacy of veterinary medicine “Trifuzol 2, 5% Solution for Injection” and comparative characteristics according to available domestic analogues. “Trifuzol 2, 5% Solution for Injection” has an antioxidant, immuno-modulating, anti-inflammatory activity. The medicine increases resistance to the diseases with bacterial, viral, parasitic etiology. It is planned ahead to manufacture and sale the medicine on the internal and external pharmaceutical markets.

Keywords

Solution, trifuzol, efficacy, prevention, treatment